Erin Wendell

Erin Wendell serves as the President of ivWatch, directing the company’s overall vision, strategy, commercialization efforts, and innovation roadmap. Since joining ivWatch in 2020 as Chief Marketing and Communications Officer, she has been instrumental in transforming market awareness, strengthening customer engagement, expanding strategic partnerships, and elevating the company’s global presence. Leveraging her expertise in messaging, market education, and brand differentiation, Erin helped position ivWatch as a global leader in IV therapy and safety and accelerated early innovation adoption. She now oversees company operations across marketing, sales, clinical, R&D, and future product development, guiding ivWatch through its next phase of commercialization and market expansion.

Under her leadership, ivWatch has gained significant industry recognition. The company was named one of Fast Company’s Most Innovative Companies, recognized in PM360’s Most Interesting Innovations, and selected as a Fierce Life Sciences Innovation Awards finalist. Erin has also been honored as one of PR Daily’s Top Women in Marketing and as a PM360 ELITE Disruptor for her work highlighting the human impact of IV injuries and driving a shift in clinical perception.

Before joining ivWatch, Erin held various leadership roles at sports icon Under Armour, helping build the brand into a household name and ending her nearly 15-year tenure there as Senior Director of Global Communications. She played a critical role in growing the company’s communications function from its inception, driving brand awareness, executing entries into global markets, launching major campaigns and products, and establishing best-in-class media and employee communications practices.

John Zwirschitz

John joined ivWatch in July 2024 and is responsible for leading the company’s accounting and finance functions. Previously, he spent 28 years in field and corporate leadership positions at Ferguson Enterprises, playing a critical role in its growth from a regional company to the largest value-added distributor serving the residential and non-residential North American construction market and a publicly traded company.

John spent his first ten years at Ferguson in the field, rising through numerous promotional roles which expanded his geographic and financial responsibilities. He then became a financial process subject matter expert, working in IT. Within two years, John had risen to a leadership team member of the 400-person IT department, where he spent seven more years working with stakeholders to propose, initiate, and deliver finance and cross-functional projects of all sizes, which focused on operational efficiency/automation, customer service, and compliance.

John then took on senior manager roles in the controllership organization, responsible for companywide accounting and financial controls in areas such as inventory, rebates, revenue recognition, AR, and AP. In these roles, he was responsible for helping transform multiple departments and business processes to help Ferguson achieve Sarbanes-Oxley compliance in preparation for Ferguson’s U.S. public listing.

Wayne Shepherd

Wayne Shepherd is a veteran healthcare sales leader with over 25 years of experience driving commercial growth across diagnostics, medical devices, and biotech. As the Vice President of U.S. Sales at ivWatch, he leads national sales strategy and execution for innovative ivWatch technology used in hospitals and clinical settings.

Previously, Wayne held senior leadership roles at companies including Pathnostics, Grenova, AccuVein, and BG Medicine, where he led market expansion efforts, built global sales teams, and secured key partnerships with GPOs, health systems, and government agencies. His leadership has contributed to multiple companies scaling from startup to market dominance.

Wayne holds an MBA from Averett University and a B.S. in Marketing Education from Virginia Tech, and is based in Richmond, Virginia.

Helen Stephens

Helen joined ivWatch in 2023 and leads the company’s international expansion plans from the United Kingdom. She is responsible for driving global sales strategy and footprint, directing the company’s expanding international distributor program and paving the way into new markets through distributors or selling directly to hospitals. She provides a wealth of knowledge to drive growth in the EMEA region and select other global high-demand markets.

Helen has a tenured 30-year diverse career as a bedside nurse and experience in medical device sales at companies including Becton Dickinson, Vygon, Smiths Medical, and most recently ICU Medical, where she served as the Infusion Product Sales Manager, EMEA. In her career, she has held various leadership roles in sales, business development, and clinical. A registered general nurse, she holds a degree from Frances Harrison College of Healthcare, University of Surrey.

Matthew Alley

Matthew Alley leads research and development at ivWatch, overseeing product design, system architecture and engineering initiatives that support the continuous advancement of ivWatch technology. Since joining the company in 2011, he has played a key role in developing the core detection algorithms, embedded software and system components that power ivWatch’s IV infiltration monitoring solutions. His work has helped shape both the original fiber optic–based system and the evolution to the SmartTouch sensor, supporting improved accuracy, clinical usability and patient comfort across care settings.

Matthew brings extensive experience in embedded systems and software development. Before ivWatch, he worked at CW Optics, where he collaborated on early versions of the technology that would become the ivWatch system. At ivWatch, his contributions have included data analysis, algorithm development, hardware integration and product miniaturization, as well as support for digital initiatives and cybersecurity readiness. Matthew continues to lead a team of engineers focused on innovation, reliability and product performance to ensure ivWatch delivers safe, effective and clinically meaningful solutions for patients and providers.

Kristi Stevens

Kristi Stevens leads business development and marketing operations at ivWatch, where she oversees commercial strategy, market development and partner engagement. She works across sales, marketing and clinical teams to support adoption of ivWatch technology and strengthen the company’s presence in healthcare systems worldwide. Her focus is on building strategic relationships, supporting customer needs and advancing the mission to make IV therapy safer for patients.

Kristi brings more than 15 years of experience in brand strategy, integrated marketing and business development. Before ivWatch, she held global brand roles at Under Armour and supported partnership and experiential programs at The Knot. She later founded a consulting practice for lifestyle and outdoor brands focused on influencer programs, content strategy and go-to-market planning. At ivWatch, Kristi is committed to developing strong collaborations that drive clinical value and sustainable growth.